Category: Pharmaceuticals
Roche, the Swiss multinational healthcare company recently unveiled new data at the San Antonio Breast Cancer Symposium that is anticipated to boost to its breast cancer drug Kadcyla. The data presented by Roche showed that Kadcyla beat Herceptin by a significant percentage in the post-surgery …
Swiss healthcare behemoth Roche Holding AG., recent unveiled that its Tecentriq immunotherapy merged with chemotherapy secured the top Priority Review approval from the U.S. watchdog. Reportedly, the Tecentriq will be used for treating a type of lung cancer – SCLC (extensive-stage small cell lung cancer). …
Norway’s pharmaceutical major Ultimovacs recently announced that in its IPO (Initial Public Offering) in early 2019, it has plans to raise about 700 million Norwegian crowns (USD 82 million). Reportedly, the company aims to develop its immunotherapy cancer drug with the help of the raised …
Reports confirm that Mumbai based Sun Pharmaceutical Industries Ltd. has recently received final approval from the U.S. Food and Drug Administration (FDA) for the company’s abbreviated new drug application (ANDA) for the generic version of Ganirelix Acetate Injection, 250 mcg/0.5 mL. Apparently, this generic version …
Japan’s in-vitro diagnostics company, Sysmex Corp. has recently announced a collaboration agreement with U.S. molecular diagnostics firm, MolecularMD Corp., to target challenges in current and future companion diagnostics (CDx) development and commercialization for accelerating precision medicines. As per trusted sources, the non-exclusive collaboration agreement is …
Roche, the Swiss drug manufacturer recently acquired the San Diego based startup Jecure Therapeutics for an undisclosed amount. According to sources the recent accrual is meant to help Roche join in the pursuit of discovering new drugs that can cure fatty liver disease. Other pharmaceutical …
The U.S. Food & Drug Administration, a regulatory body that is a part of the U.S. Department of Health and Human Services, has reportedly announced that it has given its approval to a new cancer fighting drug called Vitrakvi. Reports cite, the innovative new drug …
American retail and healthcare firms, CVS Health, and Aetna Inc. are currently in the final stage of approval for a deal to develop a new healthcare firm that includes a retail pharmacy, a health insurer, and a firm that negotiates the price clinically prescribed drug …
Renowned Indian multinational pharmaceutical giant Sun Pharmaceutical Industries Ltd. has reportedly announced that it has acquired the Japanese pharmaceutical company, Pola Pharma Inc. in a $1 million deal. Reports cite, Pola Pharma, a part of Pola Orbis group, is primarily involved in manufacturing, research & …
